| Authors: |
Postma M; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Economics, Econometrics & Finance, University of Groningen, Faculty of Economics & Business, Groningen, the Netherlands; Department of Pharmacology & Therapy, Universitas Airlangga, Surabaya, Indonesia; Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia. Electronic address: m.j.postma@rug.nl., Biundo E; GSK, Wavre, Belgium. Electronic address: eliana.8.biundo@gsk.com., Chicoye A; AC Health Consulting, Sciences Po, Paris, France. Electronic address: annie.chicoye@gmail.com., Devlin N; University of Melbourne, Melbourne, Australia. Electronic address: nancy.devlin@unimelb.edu.au., Mark Doherty T; GSK, Wavre, Belgium. Electronic address: mark.x.doherty@gsk.com., Garcia-Ruiz AJ; University of Malaga, Malaga, Spain. Electronic address: ajgr@uma.es., Jaros P; Creativ-Ceutical, London, United Kingdom. Electronic address: Patrycja.Jaros@creativ-ceutical.com., Sheikh S; GSK, Wavre, Belgium. Electronic address: shazia.x.sheikh@gsk.com., Toumi M; Creativ-Ceutical, Luxembourg, Luxembourg. Electronic address: Mondher.Toumi@creativ-ceutical.com., Wasem J; University of Duisburg-Essen, Essen, Germany. Electronic address: juergen.wasem@medman.uni-due.de., Beck E; GSK, Wavre, Belgium. Electronic address: ekkehard.x.beck@gsk.com., Salisbury D; Programme for Global Health, Royal Institute of International Affairs, Chatham House, London, United Kingdom. Electronic address: david.salisbury@btinternet.com., Nolan T; University of Melbourne, Melbourne, Australia. Electronic address: t.nolan@unimelb.edu.au. |
